ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04974	Protein digestion and absorption	10/149	96/7206	2.60137906539e-05
ko00643	Styrene degradation	3/149	4/7206	3.41405506154e-05
ko00350	Tyrosine metabolism	6/149	33/7206	4.93493984141e-05
ko04512	ECM-receptor interaction	8/149	79/7206	0.000208749741862
ko04217	Necroptosis	12/149	178/7206	0.000297421036864
ko05160	Hepatitis C	11/149	153/7206	0.000307223761945
ko05164	Influenza A	11/149	167/7206	0.000648669716689
ko04668	TNF signaling pathway	9/149	120/7206	0.00080573090142
ko05131	Shigellosis	7/149	82/7206	0.00145994205961
ko04621	NOD-like receptor signaling pathway	10/149	157/7206	0.0014742825142
ko04662	B cell receptor signaling pathway	7/149	88/7206	0.00219960658277
ko04215	Apoptosis - multiple species	5/149	47/7206	0.00269391375355
ko04510	Focal adhesion	12/149	240/7206	0.00396055668039
ko04210	Apoptosis	10/149	180/7206	0.0040150391875
ko05145	Toxoplasmosis	8/149	126/7206	0.0044486976314
ko04725	Cholinergic synapse	9/149	160/7206	0.0057775807884
ko04060	Cytokine-cytokine receptor interaction	10/149	191/7206	0.0060838891153
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/149	135/7206	0.00671790762363
ko04068	FoxO signaling pathway	9/149	167/7206	0.00759546634353
ko00120	Primary bile acid biosynthesis	3/149	20/7206	0.00763002390178
ko04213	Longevity regulating pathway - multiple species	6/149	86/7206	0.00854798942053
ko05133	Pertussis	6/149	87/7206	0.00902860938825
ko05161	Hepatitis B	9/149	173/7206	0.00947704059664
ko00140	Steroid hormone biosynthesis	4/149	41/7206	0.00981974732843
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/149	182/7206	0.0129360089533
ko04211	Longevity regulating pathway	7/149	123/7206	0.013551132784
ko04064	NF-kappa B signaling pathway	6/149	96/7206	0.0142585974369
ko04650	Natural killer cell mediated cytotoxicity	6/149	97/7206	0.0149471310321
ko05132	Salmonella infection	6/149	98/7206	0.0156584821166
ko05146	Amoebiasis	6/149	99/7206	0.0163929973833
ko05410	Hypertrophic cardiomyopathy (HCM)	6/149	100/7206	0.0171510172967
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/149	191/7206	0.0172597708876
ko04722	Neurotrophin signaling pathway	8/149	160/7206	0.0176039922927
ko05134	Legionellosis	5/149	74/7206	0.0181631676339
ko04611	Platelet activation	8/149	163/7206	0.019466773179
ko01524	Platinum drug resistance	5/149	76/7206	0.0201632032781
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/149	11/7206	0.02066798157
ko00401	Novobiocin biosynthesis	1/149	1/7206	0.0206772134333
ko04931	Insulin resistance	7/149	137/7206	0.0231539032235
ko05214	Glioma	5/149	79/7206	0.0234254272325
ko04012	ErbB signaling pathway	6/149	109/7206	0.0250837212423
ko05215	Prostate cancer	6/149	111/7206	0.0271310402101
ko04657	IL-17 signaling pathway	5/149	87/7206	0.0337316942318
ko05162	Measles	6/149	120/7206	0.0377079721981
ko04921	Oxytocin signaling pathway	9/149	209/7206	0.0408326081957
ko04151	PI3K-Akt signaling pathway	14/149	390/7206	0.0413770618749
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/149	92/7206	0.0414089979361
ko04660	T cell receptor signaling pathway	6/149	124/7206	0.0431514551694
ko00360	Phenylalanine metabolism	2/149	17/7206	0.0471481839421
ko04922	Glucagon signaling pathway	6/149	128/7206	0.0490662042703
ko04080	Neuroactive ligand-receptor interaction	3/149	423/7206	0.0495459468205